MetaVia Inc. is trading 5.5% down today at $1.90 as the stock retraces sharp gains driven by recent obesity and cardiometabolic pipeline headlines.
- The pullback follows prior surges tied to late-breaking ADA 2026 poster acceptances and an obesity/metabolic pipeline update.
- Market participants appear to be locking in profits and reassessing near-term catalysts after the initial news-driven spike.